[Advances in intercalating drugs].
Pouillart
P
P
Service de Médecine Oncologique, Institut Curie, Paris, France.
Beuzeboc
P
P
Dorval
T
T
Garcia-Giralt
E
E
Jouve
M
M
Palangie
T
T
School
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use; D015251:Epirubicin / Q000627:therapeutic use; D006801:Humans; D007364:Intercalating Agents / Q000627:therapeutic use*; D008942:Mitoxantrone / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*
D007364:Intercalating Agents; D015251:Epirubicin; D004317:Doxorubicin; D008942:Mitoxantrone
Progrès dans les intercalants.